Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Rationale Ayahuasca is a South American psychoactive beverage that contains the naturally occurring psychedelic agent N,N-dimethyltryptamine (DMT). This "tea" has been used for centuries in religious and medicinal contexts in the rain forest areas of South America and is presently gaining the attention of psychedelic users in North America and Europe. Objectives In the present study, the psychological effects and tolerability of ayvahuasca were assessed. Methods Three increasing doses of encapsulated freeze-dried ayahuasca (0.5, 0.75, and 1.0 mg DMT/kg body weight) were administered to six healthy male volunteers with prior experience in the use of this tea, in a single-blind crossover placebo-controlled clinical trial. Results Ayahuasca produced significant dose-dependent increases in five of the six subscales of the Hallucinogen Rating Scale, in the LSD, MBG, and A scales of the Addiction Research Center Inventory, and in the "liking", "good effects" and "high" visual analogue scales. Psychological effects were first noted after 30-60 min, peaked between 60-120 min, and were resolved by 240 min. The tea was well tolerated from a cardiovascular point of view, with a trend toward increase for systolic blood pressure. Modified physical sensations and nausea were the most frequently reported somatic-dysphoric effects. The overall experience was regarded as pleasant and satisfactory by five of the six volunteers, while one volunteer experienced an intensely dysphoric reaction wi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ayahuasca has been demonstrated to be safe in naturalistic (35, 108) and clinical settings, across varying dosages and multiple administrations (26, 109–112).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [109]
In the citing paper
“Ayahuasca was found to significantly raise the systolic and diastolic blood pressure by 35 Hgmm and the pulse rate by 26 bpm in a 2 min time interval while the rate of increase declines upon repeated intake (Riba et al., 2001).”
From The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization (2016) · cites this paper as Riba et al., 2001
Citations
Cites
(1970) · Cited by 24,983
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 1×
“…and cognitive modifications induced by these agents, as in another study psilocybin's subjective effects were found to be increased rather than reverted by the D 2 receptor antagonist, haloperidol , while they were effectively counteracted by ketanserin and risperidone (Vollenweider et al. 1998).”
BackgroundLane, R. D., Reiman, E. M., Axelrod, B., Yun, L.-S., Holmes, A., & Schwartz, G. E. (1998) · Journal of Cognitive Neuroscience · doi:10.1162/089892998562924 · Cited by 671 · cited 2×
“A recent PET study has implicated the ACC in normal emotional awareness (Lane et al. 1998), and psilocybin administration leads to increases in metabolism in this area, where 5-HT 2A -mediated EPSPs/EPSCs have also been recorded (Aghajanian and Marek 1997).”
BackgroundEvidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & McKenney, J. D. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 631
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444 · cited 1×
“…revealed patterns of increased metabolism throughout the brain, and more specifically in the prefrontal cortices, particularly in the right hemisphere, in healthy volunteers after dosing with psilocybin (Vollenweider et al. 1997; Gouzoulis- Mayfrank et al. 1999b) and mescaline (Hermle et al. 1992).”
BackgroundSerotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, A., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 436
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398 · cited 8×
“When compared with IV DMT, it is reasonable to assume that the reversible MAO-inhibiting properties of harmine and harmaline leads to a transient increase in endogenous monoamines, in addition to DMT's own cardiovascular effects.”
BackgroundMethodResultInfluentialHuman psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
Self-citation
Cited by
Items 101–200 of 321
Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness
Mian, M. N., Altman, B. R., & Earleywine, M. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1674428 · Cited by 46
Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review
Simão, A. Y., Gonçalves, J., Duarte, A. P., Barroso, M., Cristóvão, A. C., & Gallardo, E. (2019) · Medicines · doi:10.3390/medicines6040106 · Cited by 51
Potential use of ayahuasca in grief therapy
González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2019) · OMEGA - Journal of Death and Dying · doi:10.1177/0030222817710879 · Cited by 44
The History of Psychedelics in Medicine
Sessa, B. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_96-1 · Cited by 65
Maternal and developmental toxicity of ayahuasca in Wistar rats
de Oliveira, C. D. R., Moreira, C. Q., de Sá, L. R. M., Spinosa, H. D. S., & Yonamine, M. (2010) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20244 · Cited by 45
EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences.
Stuckey, D. E., Lawson, R., & Luna, L. E. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399798 · Cited by 43
Ayahuasca and the Treatment of Drug Addiction
Bouso, J. C., & Riba, J. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_6 · Cited by 52
Self-citationBarrett, F. S., Schlienz, N. J., Lembeck, N. A., Waqas, M., & Vandrey, R. G. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0052 · Cited by 46
Wolff, T. J., Ruffell, S., Netzband, N., & Passie, T. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.007 · Cited by 40
Gaujac, A., Navickiene, S., Collins, M. I., Brandt, S. D., & de Andrade, J. B. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1343 · Cited by 34
A Systematic Review of Study Design and Placebo Controls in Psychedelic Research
Wen, A. Q., Singhal, N., Jones, B. D. M., Zeifman, R. J., Mehta, S. H., Shenasa, M. A., Blumberger, D. M., Daskalakis, Z. J., & Weissman, C. R. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0028 · Cited by 47
Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish
Savoldi, R., Polari, D., Pinheiro‐da‐Silva, J., Silva, P. F., Soares, B. L., Yonamine, M., Freire, F. A. D. M., & Luchiari, A. C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00139 · Cited by 43
Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate
Jiménez, J. H., & Bouso, J. C. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221104054 · Cited by 42
Egger, K., Aicher, H., Cumming, P. D., & Scheidegger, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05353-6 · Cited by 47
Kaasik, H., & Kreegipuu, K. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1748773 · Cited by 31
Phenomenology of N,N-Dimethyltryptamine use : a thematic analysis
Cott, C., & Rock, A. J. (2008) · Journal of Scientific Exploration · Cited by 59
The subjective experience of acute, experimentally-induced Salvia divinorum inebriation
Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115570081 · Cited by 36
The therapeutic potentials of Ayahuasca in the treatment of depression
Palhano-Fontes, F., Alchieri, J. C., Oliveira, J. P. M., Soares, B. L., Hallak, J. E. C., Galvao-Coelho, N., & de Araujo, D. B. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_2 · Cited by 36
“The effects of ayahuasca are heterogeneous (Riba et al. 2001), and encompass sensory, cognitive, and affective changes (Prado et al.”
BackgroundRocha, J. M., Rossi, G. N., Osório, F. D. L., Bouso, J. C., Silveira, G. D. O., Yonamine, M., Crevelin, E. J., Queiroz, M. E. C., Hallak, J. E. C., & SANTOS, R. G. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.688439 · Cited by 40
Drug addiction. Part I. Psychoactive substances in the past and presence.
Vetulani, J. (2001) · PubMed · Cited by 36
Pontual, A. A. D. D., Tófoli, L. F., Corradi-Webster, C. M., van Oorsouw, K. I. M., Delgado, A. R. O., & Ramaekers, J. G. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.857372 · Cited by 38
Viol, A., Palhano-Fontes, F., Onias, H., de Araújo, D. B., Hövel, P., & Viswanathan, G. M. (2019) · Entropy · doi:10.3390/e21020128 · Cited by 40
The Altered States Database: Psychometric data from a systematic literature review
Prugger, J., Derdiyok, E., Dinkelacker, J., Costines, C., & Schmidt, T. T. (2022) · Scientific Data · doi:10.1038/s41597-022-01822-4 · Cited by 36
Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?
Malcolm, B. J., & Lee, K. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.01.039 · Cited by 28
Aicher, H. D., Mueller, M. J., Dornbierer, D. A., Suay, D., Elsner, C., Wicki, I., Meling, D., Caflisch, L., Hempe, A., Steinhart, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1302559 · Cited by 33
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine
O’Shaughnessy, D. M., Berlowitz, I., Rodd, R., Sarnyai, Z., & Quirk, F. H. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320986634 · Cited by 33
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Bouso, J. C., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Biomolecules · doi:10.3390/biom12111618 · Cited by 40
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy
Orsolini, L., Chiappini, S., Papanti, D., Latini, R., Volpe, U., Fornaro, M., Tomasetti, C., Vellante, F., & Berardis, D. D. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2728 · Cited by 37
Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation.
Frecska, E., White, K. D., & Luna, L. E. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1701-x · Cited by 32
“agery, auditory hallucinations, cognitive changes, and depersonalization-derealization type phenomena with profound modification in the sense of self and reality (Szara 1956; Strassman 1996; Riba et al. 2001).”
BackgroundRush, B. R., Marcus, O., García, S., Loizaga-Velder, A. K., Loewinger, G. C., Spitalier, A., & Mendive, F. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.659644 · Cited by 37
Hallucinogenic botanicals of America: A growing need for focused drug education and research
Halpern, J. H., & Sewell, R. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.005 · Cited by 32
Anderson, B. T., Labate, B. C., Meyer, M. J., Tupper, K. W., Barbosa, P. C. R., Grob, C. S., Dawson, A., & McKenna, D. J. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2012.02.007 · Cited by 41
Psychedelics and mindfulness: A systematic review and meta-analysis
Radakovic, C., Radaković, R., Peryer, G., & Geere, J. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00218 · Cited by 34
Falchi-Carvalho, M., Wießner, I., Silva, S. R. B., Maia, L. O., Barros, H., Laborde, S., Arichelle, F., Tullman, S., Silva-Costa, N., Assunção, A., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.12.006 · Cited by 37
Acute Intoxication following Dimethyltryptamine Ingestion
Bilhimer, M. H., Schult, R. F., Higgs, K. V., Wiegand, T. J., Gorodetsky, R. M., & Acquisto, N. M. (2018) · Case Reports in Emergency Medicine · doi:10.1155/2018/3452691 · Cited by 30
Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry
Anderson, B. T. (2012) · Anthropology of Consciousness · doi:10.1111/j.1556-3537.2012.01056.x · Cited by 43
Plant Poisons and Traditional Medicines
Aronson, J. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00077-7 · Cited by 36
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodríguez, C. I., Kalin, N. H., & McDonald, W. M. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19104 · Cited by 28
Jones, P. N. (2006) · Anthropology of Consciousness · doi:10.1525/ac.2006.17.2.4 · Cited by 27
da Silva, M. G., Daros, G. C., & de Bitencourt, R. M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113003 · Cited by 28
A Systematic Review on the Therapeutic Effects of Ayahuasca
Gonçalves, J., Luís, Â., Gallardo, E., & Duarte, A. P. (2023) · Plants · doi:10.3390/plants12132573 · Cited by 34
Les effets de l’ayahuasca sur le système nerveux central: étude comportementale
Lima, L. M., Ferreira, S. M., Ávila, A. A. L., Perazzo, F. F., Schneedorf, J. M., Hinsberger, A., & Carvalho, J. C. T. (2007) · Phytothérapie · doi:10.1007/s10298-007-0266-y · Cited by 27
Ayahuasca for the Treatment of Depression
Palhano-Fontes, F., Soares, B. L., Coelho, N. L. G., Arcoverde, E., & de Araújo, D. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_277 · Cited by 35
Neuroanthropology: evolution and emotional embodiment
Campbell, B., & Garcia, J. R. (2009) · Frontiers in Evolutionary Neuroscience · doi:10.3389/neuro.18.004.2009 · Cited by 32
Gómez-Sousa, M. D. L., Jiménez-Garrido, D. F., Oña, G., SANTOS, R. G. D., Hallak, J. E. C., Alcázar‐Córcoles, M. Á., & Bouso, J. C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001343 · Cited by 31
Rodd, R. (2008) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2008.10400645 · Cited by 28
Kohek, M., Ona, G., van Elk, M., Dos Santos, R. G., Hallak, J. E. C., Alcázar-Córcoles, M. Á., & Bouso, J. C. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2077155 · Cited by 24
The illusion of knowledge in the emerging field of psychedelic research
Oña, G., Kohek, M., & Bouso, J. C. (2022) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2022.100967 · Cited by 28
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Rossi, G. N., Dias, I. C. D. S., Baker, G. B., Bouso, J. C., Dursun, S. M., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2054988 · Cited by 23
A lexicon for psychedelic research and treatment
Nutt, D. J., Erritzøe, D., Schlag, A. K., Luke, D. P., Mash, D. C., Uchida, H., Aday, J. S., Rucker, J., Galindo, L., Sweeney, M., et al. (2025) · Drug Science Policy and Law · doi:10.1177/20503245251380511 · Cited by 25
Labate, B. C., & Cavnar, C. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.09.002 · Cited by 27
The current state of ayahuasca research in animal models: A systematic review
Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 23
An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice
Correa-Netto, N. F., Masukawa, M. Y., Nishide, F., Galfano, G. S., Tamura, F., Shimizo, M. K., Marcato, M. P., Santos-Junior, J. G., & Linardi, A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176036 · Cited by 26
Acute Effects of 2C-E in Humans: An Observational Study
Papaseit, E., Olesti, E., Pérez‐Mañá, C., Torrens, M., Grifell, M., Ventura, M., Pozo, Ó. J., Perna, E. B. D. S. F., Ramaekers, J. G., de la Torre, R., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00233 · Cited by 22
The Power of Social Attribution: Perspectives on the Healing Efficacy of Ayahuasca
de Mori, B. B. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.748131 · Cited by 26
Schenberg, E. E., & Gerber, K. (2022) · Transcultural Psychiatry · doi:10.1177/13634615211062962 · Cited by 22
Shared functional connectome fingerprints following ritualistic ayahuasca intake
Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K. I. M., Toennes, S. W., Tolle, H. M., Amico, E., & Ramaekers, J. G. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120480 · Cited by 20
A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers
Ables, J. L., Israel, L., Wood, O., Govindarajulu, U., Fremont, R., Banerjee, R., Liu, H.-T., Cohen, J., Wang, P., Kumar, K., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241273772 · Cited by 18
Ayahuasca: Pharmacology, Safety, and Therapeutic Effects
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009585330.005 · Cited by 24
Effectiveness of Psilocybin on Depression: A Qualitative Study
Alshaikhli, H., Al-Naggar, R. A., & Erlam, G. D. (2021) · Electronic Journal of General Medicine · doi:10.29333/ejgm/10862 · Cited by 23
Daldegan‐Bueno, D., Révész, D., Morais, P. R., Barbosa, P. C. R., & Maia, L. O. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2063896 · Cited by 21
Greene, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00015-8 · Cited by 27
Ayahuasca psychedelic tested for depression
Frood, A. (2015) · Nature · doi:10.1038/nature.2015.17252 · Cited by 20
Egger, K., Gudmundsen, F., Jessen, N. S., Baun, C., Poetzsch, S. N., Shalgunov, V., Herth, M. M., Quednow, B. B., Martin-Söelch, C., Dornbierer, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1140656 · Cited by 21
Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users
Mello, S. M., Soubhia, P. C., Silveira, G. D. O., Correa-Netto, N. F., Lanaro, R., Costa, J. L., & Linardi, A. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1557355 · Cited by 19
Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study
Aday, J. S., Bloesch, E. K., Davis, A. K., Domoff, S. E., Scherr, K. C., Woolley, J. D., & Davoli, C. C. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2312980 · Cited by 20
Oña, G., & Bouso, J. C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666191212103330 · Cited by 19
González, D., Aixalà, M., Neimeyer, R. A., Cantillo, J., Nicolson, D., & Farré, M. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.832879 · Cited by 19
Moderators of ayahuasca’s biological antidepressant action
de Sousa, G. M., Tavares, V. D. D. O., Galvão, A. C. D. M., de Almeida, R. N., Palhano-Fontes, F., Soares, B. L., Freire, F. A. D. M., Nunes, E. A., Maia‐de‐Oliveira, J. P., Perkins, D., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1033816 · Cited by 26
Ayahuasca: what mental health professionals need to know
SANTOS, R. G. D., Bouso, J. C., & Hallak, J. E. C. (2017) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000130 · Cited by 25
Tavares, L. S., Monedeiro, F., Bordin, D. M., & Martinis, B. S. D. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz116 · Cited by 19
Madrid-Gambín, F., Gomez‐Gómez, À., Busquets-García, A., Haro, N., Marco, S., Mason, N. L., Reckweg, J. T., Mallaroni, P., Kloft, L., van Oorsouw, K. I. M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112845 · Cited by 18
Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation
Daneluz, D. M., Sohn, J. M. B., Silveira, G. D. O., Yonamine, M., & Stern, C. A. J. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06217-2 · Cited by 22
van Oorsouw, K. I. M., Uthaug, M. V., Mason, N. L., Broers, N. J., & Ramaekers, J. G. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00174 · Cited by 20
Ramaekers, J. G., Mallaroni, P., Kloft, L., Reckweg, J. T., Toennes, S. W., van Oorsouw, K. I. M., & Mason, N. L. (2023) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_02003 · Cited by 16
Human behavioral pharmacology of psychedelics
Strickland, J. C., & Johnson, M. W. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.003 · Cited by 16
Lauria, P. S. S., Gomes, J. D. M., Abreu, L. S., Santana, R. C., Nunes, V. L. C., Couto, R. D., Colavolpe, P. O., da Silva, M. S., Soares, M. B. P., & Villarreal, C. F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117710 · Cited by 14
Egger, K., Redondo, J. J., Müller, J., Dornbierer, J., Smallridge, J. W., Aicher, H., Meling, D., Müller, P., Kost, J., Puchkov, M., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117908 · Cited by 15
Rossi, G. N., Rocha, J. M., Osório, F. D. L., Bouso, J. C., Oña, G., Silveira, G. D. O., Yonamine, M., Bertozi, G., Crevelin, E. J., Queiroz, M. E. C., et al. (2023) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001691 · Cited by 13
Campagnoli, A. P. S., Pereira, L. A. S., & Bueno, J. L. O. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209278 · Cited by 14
Ayahuasca: uma revisão dos aspectos farmacológicos e toxicológicos
Pires, A. P. S., de Oliveira, C. D. R., & Yonamine, M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 54
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
Bouso, J. C., Oña, G., Kohek, M., SANTOS, R. G. D., Hallak, J. E. C., Alcázar‐Córcoles, M. Á., & Obiols‐Llandrich, J. (2023) · Culture Medicine and Psychiatry · doi:10.1007/s11013-022-09814-0 · Cited by 15
Nižňanský, Ľ., Nižnanská, Ž., Kuruc, R., Szórádová, A., Šikuta, J., & Zummerová, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041147 · Cited by 16
van den Berg, M., Magaraggia, I., Schreiber, R., Hillhouse, T. M., & Porter, J. H. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06106-8 · Cited by 13
Hallucinogen Rating Scale (HRS) - Versão brasileira: tradução e adaptação transcultural
Mizumoto, S., da Silveira, D. X., Barbosa, P. C. R., & Strassman, R. J. (2011) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832011000600004 · Cited by 19
Ayahuasca Alters Structural Parameters of the Rat Aorta
Pitol, D. L., Siéssere, S., SANTOS, R. G. D., Rosa, M. L. N. M., Hallak, J. E. C., Scalize, P. H., Pereira, B. F., Iyomasa-Pilon, M. M., Semprini, M., Riba, J., et al. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000243 · Cited by 15
Self-citationFrecska, E., White, K. D., & Luna, L. E. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400019 · Cited by 12
“In this com b inat ion, D M T is capable of e l i c i t ing an intensely emotional, dream-like experience characterized by vivid v isual imagery, perceptual and cognitive changes, and pro found, meaningful modification in the sense of self and reality (Riba et al. 2001 ; Strassman 200 I ).”
BackgroundAyahuasca: Between Cognition and Culture
Peláez, I. E. A. (2020) · Publicacions URV eBooks · doi:10.17345/9788484248347 · Cited by 11
Martins, C. P. B., Freeman, S., Alder, J. F., & Brandt, S. D. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.06.060 · Cited by 11
Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay
Kummrow, F., Maselli, B. D. S., Lanaro, R., Costa, J. L., Umbuzeiro, G. D. A., & Linardi, A. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22263 · Cited by 13
Mueller, M. J., Aicher, H., Dornbierer, D., Marten, L., Suay, D., Meling, D., Elsner, C., Wicki, I. A., Müller, J., Poetzsch, S. N., et al. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf001 · Cited by 14
Ayahuasca in the Czech Republic: Extended Version
Horák, M., & Verter, N. (2019) · doi:10.11118/978-80-7509-657-9 · Cited by 12
Hosanagar, A., Cusimano, J. M., & Radhakrishnan, R. (2021) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20ac13786 · Cited by 13
Adverse Effects After Ayahuasca Administration in the Clinical Setting
Rocha, J. M., Rossi, G. N., Osório, F. L., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001536 · Cited by 10
Can Ayahuasca and sleep loss change sexual performance in male rats?
Alvarenga, T. A., Polesel, D. N., Matos, G., Garcia, V. A., Costa, J. L., Tufik, S., & Andersen, M. L. (2014) · Behavioural Processes · doi:10.1016/j.beproc.2014.09.024 · Cited by 10
Plants with Anti-Addictive Potential
Konrath, E. L., Arbo, M. D., Arbo, B. D., Hort, M. A., Elisabetsky, E., & Leal, M. B. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-64872-5_14 · Cited by 11
Episodios psicóticos inducidos por ayahuasca: revisión sistemática a partir de un caso.
Alcantarilla, L., García-Alcarria, E., & Almonacid, C. (2022) · Revista de Neuro-Psiquiatría · doi:10.20453/rnp.v85i3.4331 · Cited by 10
Ayahuasca: entre o legal e o cultural
Garrido, R. G., & Sabino, B. D. (2009) · Saúde Ética & Justiça · doi:10.11606/issn.2317-2770.v14i2p44-53 · Cited by 15
Psychedelics and fNIRS neuroimaging: exploring new opportunities
Scholkmann, F., & Vollenweider, F. X. (2022) · Neurophotonics · doi:10.1117/1.nph.10.1.013506 · Cited by 9
AYAHUASCA: neuroquímica e farmacologia
SANTOS, R. G. D. (2007) · SMAD Revista Eletrônica Saúde Mental Álcool e Drogas (Edição em Português) · doi:10.11606/issn.1806-6976.v3i1p01-11 · Cited by 18
Metadata
- Authors
- Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J.
- Affiliations
- Hospital de Sant Pau (ES)
- University of Eastern Finland (FI)
- Venue
- Psychopharmacology
- Published
- 2001-02-22
- Volume
- 154
- Issue
- 1
- Pages
- 85-95
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2036881116
- Cited by
- 303
- References
- 31
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 15 · 2023: 22 · 2022: 35 · 2021: 24 · 2020: 20 · 2019: 12 · 2018: 13 · 2017: 18 · 2016: 14 · 2015: 15 · 2014: 8 · 2013: 8 · 2012: 15
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- ayahuasca, N,N-dimethyltryptamine, DMT, psychedelic effects, subjective experience, tolerability, dose-response relationship, Addiction Research Center Inventory, cardiovascular effects, nausea, healthy volunteers
- MeSH terms
- Adult, N,N-Dimethyltryptamine, Hallucinogens, Hemodynamics, Humans, Male, Plant Extracts, Plants, South America, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.